Phytotherapy for prevention of atherosclerosis-associated early cerebral ischemia

Current Drug Metabolism

28 March Mar 2018 4 months ago
  • Myasoedova VA

Cerebrovascular disease caused by atherosclerosis affecting cerebral and pre-cerebral arteries is one of the leading causes of morbidity and mortality in high-income countries. Medications of botanical origin are often characterized by good tolerability and are suitable for long-term treatment. Therefore, phytotherapy provides an interesting possibility for developing new therapies for prevention of atherosclerosis and its complications that could be used at preclinical stages of the disease. We reviewed the current literature studying the potential of various plant-based medications for prevention and treatment of early cerebral ischemia induced by atherosclerosis.

Reference
Kirichenko TV, Myasoedova VA, Sobenin IA, Orekhov AN. Phytotherapy for prevention of atherosclerosis-associated early cerebral ischemia. Curr Drug Metab 2018 Mar 5. doi: 10.2174/1389200219666180305151601. [Epub ahead of print]

Go to PubMed